Panax Ginseng ： Age-Related Cognitive Decline

Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpanax\u002Dginseng\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

結論

Key Study Findings

Animal study

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …

Dose: None vs: Placebo 効果: None None

Review

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.

Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Review

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.

Dose: None vs: None Outcome: AD pharmacotherapeutic target modulation 効果: None None

対象集団: Alzheimer's disease patients (review)

Review

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.

Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Systematic Review

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.

Dose: None vs: placebo Outcome: None 効果: None None

対象集団: healthy adults

Other

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.

Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Key Statistics

研究数

1500

参加者数

↔

Mixed

グレード

Referenced Papers

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. Review

Nutritional neuroscience 2025 14 件の引用

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. Other

Psychopharmacology 2025 5 件の引用

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. Review

Degenerative neurological and … 2024 66 件の引用

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Review

Journal of clinical … 2021 38 件の引用

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. Systematic Review

Journal of alternative … 2021 13 件の引用

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. Other

Alzheimer's research & … 2021 1 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:: 200-400 mg/day standardized to 4-7% ginsenosides

上限量： Not established; up to 3,000 mg/day used short-term

研究で検討された用量

用量	期間	効果	N
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--

推奨摂取タイミング： Morning; cycling recommended (8 weeks on, 2 weeks off)

Safety & Side Effects

報告されている副作用

⚠ Insomnia
⚠ Headache
⚠ Gastrointestinal discomfort
⚠ Changes in blood pressure
⚠ Rare: hypoglycemia

既知の相互作用

● Anticoagulants and antiplatelet drugs
● Antidiabetic drugs (may lower blood sugar)
● MAO inhibitors (may potentiate effects)
● Stimulants (additive stimulatory effects)

耐容上限摂取量： Not established; up to 3,000 mg/day used short-term

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Panax Ginseng help with Age-Related Cognitive Decline?

Based on 15 studies with 1,500 participants, there is limited but promising evidence that Panax Ginseng may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Panax Ginseng should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 200-400 mg/day standardized to 4-7% ginsenosides. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Panax Ginseng?

Reported side effects may include Insomnia, Headache, Gastrointestinal discomfort, Changes in blood pressure. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Panax Ginseng and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.

Related Evidence

に関する他の成分： Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Ginkgo biloba C

Panax Ginseng 他の症状・状態について

Mental Fatigue C

総合評価

Evidence Strength52%

Moderate confidence

研究の内訳

RCT (0)Meta (0)Other (15)

代替成分との比較

この症状に対する他の成分との比較をご覧ください。

に関するすべての成分を見る： Age-Related Cognitive Decline

詳しく見る

FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。